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Abstract
Background: Leukemia is the most common childhood cancer. With the exception of Down
syndrome, prenatal radiation exposure, and higher birth weight, particularly for acute lymphoid
leukemia (ALL), few risk factors have been firmly established. Translocations present in neonatal
blood spots and the young age peak of diagnosis suggest that early-life factors are involved in
childhood leukemia etiology.
Methods: We investigated the association between birth characteristics and childhood leukemia
through linkage of the Minnesota birth and cancer registries using a case-cohort study design. Cases
included 560 children with ALL and 87 with acute myeloid leukemia (AML) diagnoses from 28 days
to 14 years. The comparison group was comprised of 8,750 individuals selected through random
sampling of the birth cohort from 1976–2004. Cox proportional hazards regression specific for
case-cohort studies was used to compute hazard ratios (HR) and 95% confidence intervals (CIs).
Results: Male sex (HR = 1.41, 95% CI 1.16–1.70), white race (HR = 2.32, 95% CI 1.13–4.76), and
maternal birth interval ≥ 3 years (HR = 1.31, 95% CI 1.01–1.70) increased ALL risk, while maternal
age increased AML risk (HR = 1.21/5 year age increase, 95% CI 1.0–1.47). Higher birth weights
(>3798 grams) (HRALL = 1.46, 1.08–1.98; HRAML = 1.97, 95% CI 1.07–3.65), and one minute
Apgar scores ≤ 7 (HRALL = 1.30, 95% CI 1.05–1.61; HRAML = 1.62, 95% CI 1.01–2.60) increased
risk for both types of leukemia. Sex was not a significant modifier of the association between ALL
and other covariates, with the exception of maternal education.
Conclusion: We confirmed known risk factors for ALL: male sex, high birth weight, and white
race. We have also provided data that supports an increased risk for AML following higher birth
weights, and demonstrated an association with low Apgar scores.
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Background
Leukemia is the most common cancer occurring in chil-
dren under age 15 in the United States with an annual
incidence of 45.5 cases per million [1]. Most cases occur
in children less than 5 years with a peak incidence at 2–3
years [2]. Translocations commonly found in childhood
leukemia have been detected in neonatal blood spots, in
some cases more than 10 years before the onset of disease
[3]. The early age at which leukemia diagnoses occur
together with the presence of leukemic translocations
detected at birth implicates a role for prenatal exposures
in childhood leukemia etiology.
Birth characteristics and risk of childhood leukemia have
been the focus of many studies and have been addressed
in several reviews [2,4,5]. Variables previously examined
include parental sociodemographic characteristics, mater-
nal reproductive history, pregnancy conditions, labor and
delivery factors, and infant characteristics. Despite dec-
ades of research, few definitive risk factors have been iden-
tified. The weight of the evidence to date indicates that
prenatal exposure to diagnostic radiation, certain genetic
syndromes (particularly Down syndrome), male sex, and
high birth weight occur more frequently in children sub-
sequently diagnosed with leukemia [2,5].
The objective of this study was to examine the relation
between characteristics recorded in birth records and
childhood leukemia using a case-cohort study design
which is relatively resistant to recall and selection biases
that are of concern in case-control studies of childhood
leukemia that frequently use survey based data collection
methods.
Methods
Study population
All childhood cancer cases diagnosed from 1988–2004
between the ages of 28 days and 14 years were ascertained
from the Minnesota Cancer Surveillance System (MCSS)
and linked to their birth records through probabilistic
record linkage [6]. It is estimated that MCSS ascertains
99.9% of cancer cases [7]. A case-cohort study design was
implemented, for which a comparison group was selected
without regard to case status and is referred to as the sub-
cohort [8]. In particular, four children per cancer case were
randomly selected from births recorded among Minne-
sota residents during 1976–2004, matching on birth year.
To maintain consistent exclusion criteria between cases
and the sub-cohort, subjects who died during the neona-
tal period who were born in 1980 (the earliest year neona-
tal deaths were recorded) or later were excluded. For the
present analysis, childhood cancer cases other than leuke-
mia were excluded, resulting in more than four sub-cohort
children matched to each case. One subject with a diagno-
sis of AML following lymphoma was excluded due to the
possibility that the AML was therapy related. Individuals
with reported Down syndrome (n = 14) were also
excluded from all analyses except where noted. The Uni-
versity of Minnesota Institutional Review Board (IRB), the
Minnesota Department of Health (MDH) IRB, and the
MCSS approved all protocols for data use.
Childhood leukemia case groups were defined according
to the International Classification of Childhood Cancer
(ICCC) code [9] and included: 1) acute lymphoblastic
leukemia (ALL), 2) acute myeloid leukemia (AML), 3)
chronic myeloproliferative disease, 4) myelodysplastic
syndrome and other myeloproliferative disease and 5)
unspecified and reticuloendothelial leukemias.
Variables
Birth certificate variables that were examined included:
parental sociodemographic characteristics: parental age,
parental race, maternal birthplace, education, marital sta-
tus; maternal reproductive characteristics: plurality, previ-
ous live births, prior fetal loss, last fetal death and live
birth intervals; index pregnancy conditions: anemia, dia-
betes (none, pre-existing or gestational), hypertension
(none, chronic, pregnancy-associated or eclampsia), ade-
quacy of prenatal care index [10]; labor and delivery char-
acteristics: labor induction, delivery method; and infant
characteristics: sex, birth weight categorized by percentile
and as a linear term, size for gestational age, gestational
age in weeks, one and five minute Apgar score, assisted
ventilation, Down syndrome, and congenital abnormali-
ties. Two gestational age variables were available in birth
records: 1) imputed from last menstrual period and 2) the
physician's estimate. The physician's estimate of gesta-
tional age was used where the imputed gestational age was
missing (n = 644 (7.3%)). Size for gestational age was cal-
culated using the derived gestational age variable accord-
ing to the method of Brenner et al [11].
Statistical analysis
SAS version 9.1 (SAS Institute, Cary, NC) was used for all
statistical analyses. A modification of the stratified Cox
proportional hazards model was used to compute risk
estimates using a macro written by Langholz and Jiao [8]
that computes standard errors using an asymptotic vari-
ance estimator appropriate for the analysis of case-cohort
designs. All models were stratified by birth year. Person-
years of follow-up was calculated as the time from birth to
cancer diagnosis date, the age the child turned 15, or the
age of the subject on 12/31/2004, whichever came first
with modification of follow-up time for cases who were
also selected in the sub-cohort (n = 3) [8].
Variables were selected for multivariate models using a
likelihood-ratio (LR) chi-square p-value cut-off of 0.1 for
ALL comparing the intercept only model to that contain-BMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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ing the covariate. For AML, only results from birth year
stratified models are reported due to the small number of
AML cases. Heterogeneity in ALL risk factors by sex or age
group (<5 vs. 5–14 years) were examined by including an
interaction term between sex or age group and the variable
of interest. Tests of statistical significance for heterogene-
ity of risk were conducted using the test statement in
PROC PHREG using a statistical criterion of p < 0.05.
Results
A total of 831 cases of leukemia occurring in children
diagnosed from 28 days through 14 years were ascer-
tained by MCSS from 1988–2004. Of these, 695 (84%)
were matched to birth records including 12 leukemia
cases with Down syndrome (Table 1). Linkage success
decreased by age at diagnosis with 88.9%, 84.1%, and
68.4% of cases matching in the 0–4, 5–9, and 10–14 year
old age groups respectively. ALL diagnoses were most fre-
quent (81%), followed by AML (14%), chronic myelopro-
liferative disease (1.7%), myelodysplastic syndrome and
other myeloproliferative diseases (1.0%), and unspecified
and reticuloendothelial leukemias (2.6%). The majority
of cases occurred in children under age 5 years for both
ALL and AML (Table 1). Due to the small number of cases
with other leukemia types, further analyses were limited
to ALL and AML cases.
Table 2 reports birth year adjusted results of regression
modeling for the association between parental character-
istics and childhood leukemia. Maternal education greater
than high school increased the risk for ALL (HR = 1.21,
95% CI, 1.0–1.47), while maternal report of black com-
pared to white race in birth records decreased the risk by
approximately 60%. Factors associated with an increased
risk for AML were maternal age (HR = 1.21 per 5 year
increase, 95% CI, 1.0–1.47), and maternal foreign birth-
place (HR = 2.18, 95% CI, 1.14–4.18). No particular
national origin was overrepresented; three cases each had
mothers who were reported to have been born in Laos and
Canada, while one case mother each was born in Ger-
many, El Salvador, Korea, Nigeria, and Peru. Similar asso-
ciations were found for ALL for paternal age and race and
for AML for paternal age. No other significant associations
were found for paternal characteristics: race (AML), or
education (ALL and AML) (data not shown).
Regression results for maternal reproductive, pregnancy
and labor and delivery characteristics are reported in Table
3. Children whose mothers had a last fetal death interval
of <3 years compared to those whose mothers had no fetal
deaths were at an increased risk for ALL (HR = 1.30, 95%
CI, 1.00–1.69). Children who were 3 or more years
younger than their previous live born sibling compared to
those who had no live siblings were also at an increased
risk for ALL (HR = 1.40, 95% CI, 1.12–1.75). No other
notable differences were found for maternal reproductive
variables. We did not find evidence to suggest differences
in pregnancy history or labor and delivery characteristics
between cases and the sub-cohort with the exception of a
marginally significant decreased risk for AML associated
with less than adequate prenatal care (HR = 0.57, 95% CI
0.33–1.0) and an increased AML risk associated with
maternal gestational weight gain of 30 or more pounds
(HR = 2.59, 95% CI 1.27–5.31) based on few cases. Of
note is that the association between maternal gestational
weight gain and AML remained after adjustment for birth
weight (data not shown).
Several notable associations were found between ALL and
AML and infant characteristics (Table 4). Male sex
increased the risk for ALL (HR = 1.38, 95% CI 1.16–1.65)
only. Birth weight was positively associated with both ALL
and AML with HRs of 1.12 (95% CI, 1.03–1.23) and 1.33
(95% CI 1.06–1.66), respectively, for each 581 gram (1
sd) increase. When risk was examined by birth weight per-
centile, individuals above the 25th  percentile (>3117
grams) relative to those in the 5th-25th percentile (2496–
3117 grams) were at increased risk for ALL and AML. A
pattern consistent with a linear relation between birth
weight and ALL was observed for all percentile categories
Table 1: Distribution of leukemia cases diagnosed in 0–14 year olds in Minnesota from 1988–2004.
Age group
0–4 years 5–9 years 10–14 years Total
Acute lymphoblastic leukemia* 320 (56%) 163(29%) 79 (14%) 562(81%)
Acute myeloid leukemia+ 55 (57%) 20 (21%) 21 (22%) 96 (14%)
Chronic myeloproliferative disease 6 (50%) 3 (25%) 3 (25%) 12 (1.7%)
Myelodysplastic syndrome and other myeloproliferative diseases 4 (57%) 2 (29%) 1 (14%) 7 (1.0%)
Unspecified and reticuloendothelial leukemias 6 (33%) 8 (44%) 4 (22%) 18 (2.6%)
Total 391 (56%) 196 (28%) 108 (16%) 695
*includes 2 individuals with Down syndrome
+includes 10 individuals with Down syndromeBMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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above the reference with the highest risk for individuals
above the 95th percentile (HR = 1.82, 95% CI, 1.22–2.73).
Large size for gestational age (HRALL = 1.30, 95% CI, 1.07–
1.59, HRAML = 1.51; 95% CI, 0.95–2.40), and low one
minute Apgar scores (HRALL = 1.32, 95% CI, 1.08–1.61,
HRAML = 1.62, 95% CI, 1.01–2.60) increased the risk for
both leukemia subtypes. Down syndrome was associated
with an increased risk for ALL of 19.8 (95% CI, 2.64–
148.59) and for AML of approximately 300-fold (HR =
330, 95% CI, 94–1161) (data not shown), similar to what
has been previously reported [12].
No statistically significant differences in risk between
sexes were noted for any parental or infant characteristics
for ALL with the exception of maternal education (p =
0.04) in birth year adjusted models, which was associated
with an approximately thirty percent increased risk for
males whose mothers had education beyond high school
but not females (data not shown).
We conducted multivariate analyses for cases diagnosed at
0–14 years of age (Table 5) and by age strata (0–4 years,
5–14 years) (data not shown). Multivariate models
included: maternal age, maternal ethnicity, last live birth
interval, sex, one minute Apgar score, maternal education,
birth weight percentile category and gestational age cate-
gory. Risk estimates were generally similar to birth year
adjusted results for cancers diagnosed 0–14 (Table 5). No
statistically significant variation in risk between age
groups (0–4 years vs. 5–14 years) or sex was found for var-
iables included in multivariate models.
Discussion
The results of this study confirm previously established
risk factors for ALL: male sex, white race, and higher birth
weights. Further, children whose siblings were born three
or more years prior were at an increased risk for ALL, while
those who had low one minute Apgar scores were at an
increased risk for both leukemia subtypes. Risks for ALL
by age group and sex were generally similar with the
exception of that for maternal education in males.
Mothers of AML cases reported being foreign born more
often than those of sub-cohort members. However, there
was no distinct pattern in maternal nationality suggesting
that this association may be a chance finding. AML cases
were also more likely to have received inadequate prenatal
care. However, a biological rationale for this association is
lacking leading us to conclude that random variation is a
more plausible explanation.
Mothers of AML cases were also more likely to have
gained ≥30 pounds during their pregnancy in contrast to
another study that showed no increased risk for AML asso-
ciated with maternal gestational weight gain in excess of
thirty pounds [13]. It is of interest to examine maternal
weight gain and risk of leukemia because of its connection
with macrosomia [14] which was associated with an
Table 2: Birth year adjusted analyses of parental sociodemographic characteristics and childhood leukemia.
Sub-cohort ALL AML
No. (%) No. (%) HR 95% CI No. (%) HR 95% CI
Maternal age (continuous/5 year increase) 8750 559 1.05 0.97–1.14 87 1.21 1.00–1.47
missing 0 1 0
Maternal Race
black 324 (4) 9 (2) 0.41 0.21–0.79 4 (5) 1.20 0.43–3.33
other/unknown 519 (6) 30 (5) 0.87 0.60–1.28 6 (7) 1.16 0.50–2.68
white 7907 (90) 520 (93) ref. 77 (89) ref.
missing 0 (0) 1 (0) 0 (0)
Maternal birthplace
U.S. or U.S. territory 8226 (94) 532 (95) ref. 76 (87) ref.
foreign born 516 (6) 26 (5) 0.76 0.51–1.15 11 (13) 2.18 1.14–4.18
missing 8 (0) 2 (0) 0 (0)
Maternal Education
high school 3173 (38) 179 (34) ref. 29 (36) ref.
<high school 902 (11) 49 (9) 0.96 0.69–1.33 8 (10) 0.97 0.44–2.14
>high school 4209 (51) 301 (57) 1.21 1.00–1.47 44 (54) 1.13 0.70–1.81
missing 466 (5) 31 (6) 6 (7)
Marital status
married 6988 (80) 459 (82) ref. 75 (86) ref.
not married 1754 (20) 100 (18) 0.84 0.67–1.05 12 (14) 0.61 0.33–1.13
missing 8 (0) 1 (0) 0 (0)BMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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Table 3: Birth year adjusted analyses of maternal reproductive characteristics, pregnancy history, and labor and delivery variables and 
childhood leukemia.
Sub-cohort ALL AML
No. (%) No. (%) HR 95% CI No. (%) HR 95% CI
Plurality
1 8526 (97) 547 (98) ref. 86 (99) ND**
≥2 224 (3) 12 (2) 0.82 0.46–1.48 1 (1)
missing 1 (0) 1 (0) 0 (0)
Previous live births
0 3449 (40) 202 (37) ref. 29 (33) ref.
1–2 4251 (49) 286 (52) 1.15 0.95–1.38 49 (56) 1.39 0.87–2.20
≥3 903 (11) 61 (11) 1.14 0.85–1.54 9 (10) 1.20 0.56–2.54
missing 147 (2) 11 (2) 0 (0)
Prior fetal loss
any 1866 (22) 134 (25) 1.14 0.94–1.41 19 (22) 1.00 0.59–1.68
none 6711 (78) 407 (75) ref. 68 (78) ref.
missing 173 (3) 19 (3) 0 (0)
Last fetal death interval
no fetal deaths 6564 (80) 404 (77) ref. 67 (82) ref.
<3 years 891 (11) 73 (14) 1.30 1.00–1.69 8 (10) 0.92 0.44–1.93
≥3 years 722 (9) 51 (10) 1.13 0.83–1.53 7 (8) 0.96 0.44–2.11
missing 573 (7) 32 (6) 5 (6)
Last live birth interval
no live births 3449 (40) 202 (37) ref. 29 (35) ref.
<3 years 3333 (39) 200 (36) 1.02 0.84–1.25 34 (40) 1.22 0.74–2.02
≥3 years 1786 (21) 148 (27) 1.40 1.12–1.75 21 (25) 1.40 0.79–2.47
missing 182 (2) 10 (2) 3 (3)
Maternal diabetes*
any 110 (3) 8 (3) 1.00 0.48–2.08 0 (0) ND
none 3194 (97) 229 (97) ref. 33 (100)
missing 215 (6) 9 (4)
Gestational anemia
yes 80 (2) 8 (3) 1.52 0.72–3.19 1 (2) ND
no 4612 (98) 305 (97) ref. 42 (98)
missing 291 (6) 23 (7) 4 (9)
Maternal hypertension
any 337 (4) 28 (6) 1.32 0.88–1.96 5 (6) 1.40 0.56–3.49
none 7678 (96) 481 (94) ref. 76 (94) ref.
missing 735 (8) 51 (9) 6 (7)
Intrauterine procedures
yes 203 (2) 13 (2) 1.01 0.57–1.78 2 (2) 0.97 0.24–4.00
no 8181 (98) 515 (92) ref. 81 (98) ref.
missing 366 (4) 32 (6) 4 (5)
Maternal weight gain+
< 30 lbs 2323 (60) 148 (56) ref. 12 (36) ref.
≥ 30 lbs 1526 (40) 115 (44) 1.17 0.91–1.52 21 (64) 2.59 1.27–5.31
missing 1134 (23) 73 (22) 14 (30)
Prenatal care index†
less than adequate 2300 (33) 146 (31) 0.95 0.77–1.16 16 (22) 0.57 0.33–1.00
adequate 4747 (67) 323 (69) ref. 57 (78) ref.
missing 1151 (14) 72 (13) 11 (13)
Induction of labor‡
yes 1432 (27) 92 (27) 0.97 0.75–1.24 18 (39) 1.67 0.91–3.04
no 3878 (73) 244 (73) ref. 28 (61) ref.
missing 225 (4) 19 (5) 4 (8)
Type of delivery
vaginal 6952 82) 432 (82) ref. 73 (86) ref.
caesarean section 1485 (18) 98 (18) 1.03 0.82–1.30 12 (14) 0.75 0.41–1.39
missing 313 (4) 30 (5) 2 (2)
*collected 1992–2004.
+collected 1989–2004.
†collected 1980–2004.
‡collected 1976–1979, 1989–2004.
**ND = not determinedBMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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increased risk of AML in this study and others discussed
below. Due to small numbers we could not fully address
whether the association between higher birth weights and
AML was mediated in part through maternal weight gain.
However, within the limitations of our data, birth weight
and maternal weight gain were independent risk factors in
models that included both variables (data not shown).
AML risk increased linearly with maternal age in birth year
adjusted analyses. Of note is that maternal age also had a
significant linear effect on ALL risk in 0–4 year olds in
birth year adjusted models (data not shown). The relation
between advanced maternal age (defined as ≥35 in most
studies) and leukemia has been examined in many studies
with inconsistent findings. Studies reviewed by Little pub-
lished prior to 1998 and those since for leukemia overall
or ALL also support a slight positive association with a
mean risk estimate of around 1.2 for mothers who were
≥35 years at the time of birth compared to younger moth-
ers [4,13,15-25]. Most recent studies also generally sup-
Table 4: Birth year adjusted analyses of the association between infant characteristics and childhood leukemia.
Sub-cohort ALL AML
No. (%) No. (%) HR 95% CI No. (%) HR 95% CI
Child gender
female 4242 (49) 227 (41) ref. 43 (49) ref.
male 4501 (51) 332 (59) 1.38 1.16–1.64 44 (51) 0.97 0.64–1.49
missing 7 (0) 1 (0) 0 (0)
Birth weight
Per 1 sd increase (per 581 grams) 8710 555 1.12 1.03–1.23 87 1.33 1.06–1.66
Birth weight category
< 2496 g 406 (5) 29 (5) 1.49 0.96–2.30 2 (2) 0.86 0.19–3.94
2496–3117 g 1746 (20) 83 (15) ref. 10 (11) ref.
3118–3458 g 2192 (25) 117 (21) 1.13 0.84–1.51 23 (26) 1.85 0.88–3.91
3459–3798 g 2142 (25) 152 (27) 1.48 1.12–1.95 20 (23) 1.65 0.77–3.54
3799–4309 g 1796 (21) 137 (25) 1.59 1.20–2.11 27 (31) 2.65 1.27–5.49
≥ 4309 g 428 (5) 37 (7) 1.82 1.22–2.73 5 (6) 1.96 0.66–5.78
missing 40 (0) 5 (1) 0 (0)
Size for gestational age*
small 271 (3) 20 (4) 1.23 0.77–1.97 2 (2) 0.78 0.19–3.22
average 5708 (72) 343 (67) ref. 54 (65) ref.
large 1905 (24) 151 (29) 1.30 1.07–1.59 27 (33) 1.51 0.95–2.40
missing 314 (4) 27 (5) 1 (1)
Gestational age category*
<37 weeks 657 (8) 43 (8) 1.00 0.72–1.38 4 (5) 0.56 0.20–1.53
37–42 weeks 6938 (88) 446 (86) ref. 1 (1) ref.
>42 weeks 311 (4) 28 (5) 1.47 0.98–2.19 2 (2) 0.59 0.14–2.43
missing 292 (4) 24 (4) 1 (1)
One minute Apgar score+
0–7 1798 (23) 144 (29) 1.32 1.08–1.61 26 (33) 1.62 1.01–2.60
>7 5884 (77) 359 (71) ref. 53 (67) ref.
missing 336 (4) 34 (6) 4 (5)
Five minute Apgar score+
0–7 275 (4) 14 (3) 0.77 0.44–1.33 4 (5) 1.47 0.53–4.08
>7 7394 (96) 488 (97) ref. 75 (95) ref.
missing 349 (4) 35 (7) 4 (5)
Assisted ventilation category†
any 79 (2) 5 (2) 0.93 0.37–2.34 0 (0) ND‡
none 4548 (98) 300 (98) ref. 41 (100)
missing 356 (7) 31 (9) 6 (13)
Congenital abnormality
any 122 (1) 10 (2) 1.30 0.68–2.51 1 (1) ND
none 8100 (99) 505 (98) ref. 81 (99)
missing 528 (6) 45 (8) 5 (6)
*collected 1980–2004.
+collected 1981–2004.
†collected 1989–2004.
‡ND = not determinedBMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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port an increased risk for AML with a mean risk estimate
of approximately 1.5 for mothers who were at least 35 at
the time of birth vs. younger mothers [13,15,18,19,22-
24]. Studies that have reported risks for ALL by age group
have generally supported stronger risks for younger chil-
dren associated with older maternal ages [13,15,23,25].
Confirmation of increased risk due to advanced maternal
age may point to particular mechanisms, such as age asso-
ciated genetic changes, in need of further study that may
help to inform leukemia etiology research and reproduc-
tive decision making.
Individuals who were ≥ 3 years younger than their previ-
ous live-born sibling were at increased risk for ALL relative
to children whose mothers had no other live births.
Longer birth intervals have been associated with adverse
maternal outcomes, particularly labor complications and
pre-eclampsia [26]. In our study, the risk for ALL associ-
ated with maternal hypertension, was elevated by 30%
but was consistent with chance. Pre-eclampsia and hyper-
tension during pregnancy have been examined in at least
6 other studies with inconsistent results [4].
Substantial evidence indicates that high birth weight (≥
4000 grams) is a risk factor for childhood leukemia, par-
ticularly ALL [5]. Our results add to this evidence and are
consistent with a linear model for birth weights above
2,496 grams. The relation between high birth weight and
AML is less clear but the weight of the evidence favors an
association [5]. Our results also support a biological link
between higher birth weights and AML and favor a linear
model, within the confines of our sample size. Larger
infants may be at an increased leukemia risk due to
increased fetal insulin like growth factor 1 (IGF-1) expo-
sure [27] which has been shown to be positively corre-
lated with birth weight [28-31] and is a known mitogen
for hematopoietic cells [32]. Increased levels of circulating
IGF-1 may offer a proliferative advantage to initiated cells,
allowing increased opportunity for malignant transforma-
tion.
Low one minute Apgar scores increased the risk for both
AML and ALL. Apgar scores are used to rapidly evaluate
the general health of the infant shortly after delivery with
values above 7 considered excellent while values below 7
can indicate an infant who has undergone oxygen depri-
Table 5: Multivariate analysis of the association between factors recorded in birth records and acute lymphoblastic leukemia.*+
Sub-cohort Cases
No. (%) No. (%) HR 95% CI
Maternal age (continuous/5 year increase) 7230 481 0.97 0.88–1.08
Maternal Ethnicity
black 280 (4) 8 (2) 0.43 0.21–0.88
other/unknown 340 (5) 21 (4) 0.95 0.59–1.51
white 6610 (91) 452 (94) ref.
Maternal Education
high school 2651 (37) 160 (33) ref.
<high school 740 (10) 46 (10) 1.11 0.77–1.58
>high school 3839 (53) 275 (57) 1.18 0.95–1.47
Last live birth interval
no live births 2915 (40) 183 (38) ref.
<3 years 2783 (38) 172 (36) 1.00 0.80–1.25
≥3 years 1532 (21) 126 (26) 1.36 1.05–1.76
Child gender
female 3514 (49) 187 (39) ref.
male 3716 (51) 294 (61) 1.43 1.18–1.74
Birth weight percentile
< 5th (< 2495 g) 320 (4) 25 (5) 1.37 0.80–2.34
5th-25th (2496–3117 g) 1436 (20) 71 (15) ref.
26th-50th (3118–3458 g) 1811 (25) 105 (22) 1.17 0.85–1.60
51st-75th (3459–3798 g) 1797 (25) 130 (27) 1.37 1.00–1.86
76th-95th (3799–4309 g) 1510 (21) 115 (24) 1.40 1.02–1.92
≥95th (≥ 4309 g) 356 (5) 35 (7) 1.71 1.11–2.65
One minute Apgar score
0–7 1681 (23) 138 (29) 1.30 1.05–1.61
>7 5549 (77) 343 (71) ref.
*All variables are mutually adjusted for each other, gestational age, and birth year.
+Excludes 1599 individuals with missing data or who were born prior to 1980 (the earliest year gestational age was recorded in birth records).BMC Pediatrics 2008, 8:7 http://www.biomedcentral.com/1471-2431/8/7
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vation and is at increased risk of neonatal death [33].
Because infants with low Apgar scores often receive oxy-
gen [34], a low Apgar score could indicate an infant who
has undergone oxidative stress during delivery and/or
who has been exposed to downstream potentially carcino-
genic treatments [35]. Although oxygen exposure, as indi-
cated by assisted ventilation, was not associated with
leukemia in our study, we had inadequate power to fully
address this hypothesis. At least three studies have
reported positive associations between low Apgar scores
and childhood leukemia or childhood cancer in general
[36-38]. Two studies have reported increased risks for ALL
[36] or childhood cancer overall associated with neonatal
oxygen exposure [38]. Oxygen exposure after birth repre-
sents an understudied area with respect to childhood
leukemia. Additional data is required to fully understand
the impact of newborn medical treatments on risk.
One of the strongest and yet unexplained risk factors for
childhood ALL is male sex. We did not find any statistical
differences in risk factors by sex with the exception of
maternal education which seems unlikely to be due to
anything more than chance. Few studies have reported
sex-specific risk estimates. Three studies that examined the
birth weight association in sex-specific analyses have
reported divergent results with one study showing that the
increased risk for higher birth weights was limited to
males [39] and two others showing the opposite [22,40].
In our study risk estimates were in the same direction and
not statistically significant between sexes for birth weight
modeled as a continuous or categorical variable. A recent
review hypothesized that sex dimorphism in the risk for
complex diseases may be related to differential epigenetic
gene regulation by sex hormones [41]. Sex specific epige-
netic differences have not been explored, to our knowl-
edge, in the regulation of lymphoid cell lineage gene
expression.
A major strength of our study is the case-cohort study
design and collection of exposure data prior to disease
onset obviating recall bias of particular concern in case-
control studies frequently collecting data through paren-
tal interview after disease status is known. Retrospective
case-control studies are also susceptible to selection bias,
where estimates could be biased if the exposure distribu-
tion of the comparison population is not representative of
the source cohort. Because we randomly sampled mem-
bers of the sub-cohort from the entire birth cohort distri-
bution of cases, selection bias was avoided.
Our study also has limitations. We did not have follow-up
information on non-case members of the sub-cohort or
have knowledge of cases diagnosed prior to 1988 (the year
of inception of the cancer registry). It is also possible that
some sub-cohort members who were later diagnosed with
leukemia were not captured by MCSS due to out-migra-
tion. However, given the rarity of childhood leukemia, it
is unlikely that out-migration or missed sub-cohort diag-
noses prior to 1988 could have caused a large bias in our
results. Also of note is that the success of matching cases
captured by MCSS to birth records decreased with diagno-
sis age. The most likely reason for this is due to immigra-
tion of individuals born elsewhere which would not have
biased our results because our study was of Minnesota
born children. A number of individuals had missing data
for variables recorded in birth records. Biased estimates
from missing data occur when the data are not missing at
random [42]. We do not believe that this could have
caused a large bias in our results because the percentage of
cases compared to sub-cohort members with missing data
was similar for any given variable. Other limitations
include the validity of birth record variables; variables
with high validity include birth weight, Apgar scores, and
delivery method. Variables that are less well measured
include prenatal care, and complications of pregnancy,
labor and delivery [43]. Sociodemographic variables have
been generally found to be reliable in at least two studies
[44,45]. Most of the findings reported here are for varia-
bles that are considered accurate and therefore most likely
provide a valid estimate of risk. Finally, some of our find-
ings may have resulted from chance variation in the distri-
bution of exposures between cases and controls due to
small numbers and multiple comparisons.
Conclusion
We have reported findings from a population-based case-
cohort study of childhood leukemia in Minnesota. Our
study adds to the current knowledge of leukemia risk fac-
tors, particularly birth weight with evidence supporting a
positive linear relation between birth weight and both
ALL and AML. Our data also suggests that early-life factors
recorded in birth records do not explain the male excess
found in ALL. Further, we have shown an increased risk
between low Apgar scores and leukemia, the reasons for
which should be the subject of further investigation.
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